Literature DB >> 36129477

[Cancer Neuroscience].

Varun Venkataramani1,2,3, Frank Winkler4,5.   

Abstract

The nervous system integrates and processes information to act as master regulator of various vital, biological processes. However, increasing data suggest that the nervous system is also a key player in the initiation of cancer and cancer progression. Following the tenet that oncology follows ontogeny, it has been shown that brain tumors follow neural developmental processes. Incurable gliomas form neurite-like membrane tubes called tumor microtubes and are controlled by neurodevelopmental pathways. Tumor microtubes are used for invasion, proliferation and interconnection with other tumor cells, forming a tumor network that is therapeutically resistant. Additionally, neurons can activate tumor cells via glutamatergic synapses to drive tumor invasion and growth. The most recent knowledge of brain cancer neuroscience presented here with a focus on brain tumours has already led to new approaches for antitumour treatment.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Antitumor treatment; Brain tumors; Nervous system; Treatment resistance; Tumor network

Mesh:

Year:  2022        PMID: 36129477     DOI: 10.1007/s00115-022-01380-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.297


  2 in total

1.  Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.

Authors:  Matthias Schneider; Lea Vollmer; Anna-Laura Potthoff; Vidhya M Ravi; Bernd O Evert; Mohummad A Rahman; Shahin Sarowar; Jan Kueckelhaus; Paulina Will; David Zurhorst; Kevin Joseph; Julian P Maier; Nicolas Neidert; Paolo d'Errico; Melanie Meyer-Luehmann; Ulrich G Hofmann; Andreas Dolf; Paolo Salomoni; Erdem Güresir; Per Ø Enger; Martha Chekenya; Torsten Pietsch; Patrick Schuss; Oliver Schnell; Mike-Andrew Westhoff; Jürgen Beck; Hartmut Vatter; Andreas Waha; Ulrich Herrlinger; Dieter H Heiland
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 12.300

Review 2.  The Many Applications of Engineered Bacteriophages-An Overview.

Authors:  Bryan Gibb; Paul Hyman; Christine L Schneider
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.